123 related articles for article (PubMed ID: 35182659)
1. HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis.
Yao Y; Liu C; Wang B; Guan X; Fang L; Zhan F; Sun H; Li H; Lou C; Yan F; Lu X; Cui L; Liao Y; Han S; Yao Y; Zhang Y
Cancer Lett; 2022 May; 533():215595. PubMed ID: 35182659
[TBL] [Abstract][Full Text] [Related]
2. Homeobox B9 Promotes Colon Cancer Progression by Targeting SRSF3.
Yuan L; Cheng F; Wu Z; Li X; Shen W
Dig Dis Sci; 2023 Aug; 68(8):3324-3340. PubMed ID: 37258980
[TBL] [Abstract][Full Text] [Related]
3. Silencing of HOXB9 suppresses cellular proliferation, angiogenesis, migration and invasion of prostate cancer cells.
Xu H; Wu S; Shen X; Wu D; Qin Z; Wang H; Chen X; Sun X
J Biosci; 2020; 45():. PubMed ID: 32098919
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communication.
Hoshino Y; Hayashida T; Hirata A; Takahashi H; Chiba N; Ohmura M; Wakui M; Jinno H; Hasegawa H; Maheswaran S; Suematsu M; Kitagawa Y
Mol Cancer; 2014 May; 13():102. PubMed ID: 24885802
[TBL] [Abstract][Full Text] [Related]
5. Homeobox B9 is overexpressed in hepatocellular carcinomas and promotes tumor cell proliferation both in vitro and in vivo.
Li F; Dong L; Xing R; Wang L; Luan F; Yao C; Ji X; Bai L
Biochem Biophys Res Commun; 2014 Feb; 444(2):241-7. PubMed ID: 24462859
[TBL] [Abstract][Full Text] [Related]
6. HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFβ pathway in pancreatic cancer.
Chiba N; Ochiai S; Gunji T; Kobayashi T; Sano T; Tomita K; Kawachi S
Oncotarget; 2022; 13():747-754. PubMed ID: 35634239
[TBL] [Abstract][Full Text] [Related]
7. The E2F1-HOXB9/PBX2-CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer.
Zhang J; Chen B; Wang Y; Liu X; Yan H; Wong KY; Chan AK; Cheung AH; Chow C; Xu D; Wang S; Huang B; Liang L; Ke H; Wong CC; Wu WK; Cheng AS; Yu J; Lo KW; To KF; Kang W
J Pathol; 2023 Aug; 260(4):402-416. PubMed ID: 37272544
[TBL] [Abstract][Full Text] [Related]
8. GRP78 activates the Wnt/HOXB9 pathway to promote invasion and metastasis of hepatocellular carcinoma by chaperoning LRP6.
Xiong H; Xiao H; Luo C; Chen L; Liu X; Hu Z; Zou S; Guan J; Yang D; Wang K
Exp Cell Res; 2019 Oct; 383(1):111493. PubMed ID: 31310747
[TBL] [Abstract][Full Text] [Related]
9. MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes.
Zhu Y; Gu J; Li Y; Peng C; Shi M; Wang X; Wei G; Ge O; Wang D; Zhang B; Wu J; Zhong Y; Shen B; Chen H
Cancer Lett; 2018 Jan; 412():59-68. PubMed ID: 28987387
[TBL] [Abstract][Full Text] [Related]
10. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients.
Zhan J; Niu M; Wang P; Zhu X; Li S; Song J; He H; Wang Y; Xue L; Fang W; Zhang H
Br J Cancer; 2014 Aug; 111(5):883-93. PubMed ID: 25025961
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation.
Mileo AM; Mattarocci S; Matarrese P; Anticoli S; Abbruzzese C; Catone S; Sacco R; Paggi MG; Ruggieri A
J Exp Clin Cancer Res; 2015 Nov; 34():140. PubMed ID: 26576645
[TBL] [Abstract][Full Text] [Related]
12. An E2F1-HOXB9 transcriptional circuit is associated with breast cancer progression.
Zhussupova A; Hayashida T; Takahashi M; Miyao K; Okazaki H; Jinno H; Kitagawa Y
PLoS One; 2014; 9(8):e105285. PubMed ID: 25136922
[TBL] [Abstract][Full Text] [Related]
13. Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients.
Carbone C; Piro G; Simionato F; Ligorio F; Cremolini C; Loupakis F; Alì G; Rossini D; Merz V; Santoro R; Zecchetto C; Zanotto M; Di Nicolantonio F; Bardelli A; Fontanini G; Tortora G; Melisi D
Clin Cancer Res; 2017 Aug; 23(15):4312-4322. PubMed ID: 28298545
[No Abstract] [Full Text] [Related]
14. Overexpressed homeobox B9 regulates oncogenic activities by transforming growth factor-β1 in gliomas.
Fang L; Xu Y; Zou L
Biochem Biophys Res Commun; 2014 Mar; 446(1):272-9. PubMed ID: 24582746
[TBL] [Abstract][Full Text] [Related]
15. Kindlin-2 induced by TGF-β signaling promotes pancreatic ductal adenocarcinoma progression through downregulation of transcriptional factor HOXB9.
Zhan J; Song J; Wang P; Chi X; Wang Y; Guo Y; Fang W; Zhang H
Cancer Lett; 2015 May; 361(1):75-85. PubMed ID: 25724625
[TBL] [Abstract][Full Text] [Related]
16. Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors.
De Falco G; Leucci E; Lenze D; Piccaluga PP; Claudio PP; Onnis A; Cerino G; Nyagol J; Mwanda W; Bellan C; Hummel M; Pileri S; Tosi P; Stein H; Giordano A; Leoncini L
Blood; 2007 Aug; 110(4):1301-7. PubMed ID: 17485552
[TBL] [Abstract][Full Text] [Related]
17. HOXB9 promotes osteosarcoma cell survival and malignancy under glucose starvation via upregulating SPP1 expression.
Han J; Ji R; Zheng S; Xia X; Du W; He H; Han C; Zhao W; Li X; Wang Y; Zhang L
Biochem Pharmacol; 2024 Jun; 224():116208. PubMed ID: 38621423
[TBL] [Abstract][Full Text] [Related]
18. HOXB9 inhibits proliferation in gastric carcinoma cells via suppression of phosphorylated-Akt and NF-κB-dependent Snail expression.
Zhang L; Wu Q; He C; Liang D; Yi Q; Shi J; Wan B; Yang R; Li L; Sha S; Chang Q
Dig Liver Dis; 2019 Jan; 51(1):157-165. PubMed ID: 30314948
[TBL] [Abstract][Full Text] [Related]
19. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
20. HOXB9 promotes endometrial cancer progression by targeting E2F3.
Wan J; Liu H; Feng Q; Liu J; Ming L
Cell Death Dis; 2018 May; 9(5):509. PubMed ID: 29724991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
